Policy and Legislation
The Patient Protection and Affordable Care Act does a great deal to address insurance industry practices. The new health care reform law, however, has been rightly criticized as failing to directly and forcefully attack rising medical costs, the primary driver of insurance premiums.
An analysis of 2004 national healthcare spending by the Centers for Medicare & Medicaid Services reveals some gender delineations.
Healthcare Trust of America, Inc., a Scottsdale, Ariz.-based self-managed, non-traded real estate investment trust, has closed on a $275 million unsecured revolving credit facility.
The fate of a bill that would exempt doctors and other providers from complying with the Federal Trade Commission's Red Flags Rule now rests in the hands of President Barack Obama.
Voters would rather see Medicaid spending reduced by better managing pharmacy benefits than cutting benefits for patients or payments to providers, according to a new poll commissioned by the Pharmaceutical Care Management Association.
On Thursday the House of Representatives overwhelmingly approved a bill (H.R. 4994) that averts a 25 percent Medicare physician fee schedule cut scheduled to take effect January 1, 2011 under the statutory “sustainable growth rate” formula.
As expected, the Senate has unanimously approved a 12-month postponement of Medicare payment cuts to physicians that were set to kick in January 1, a move widely applauded by physicians' groups and senior advocates that have desperately lobbied Capitol Hill in recent weeks.
The Senate has reached a tentative deal to delay scheduled 25 percent Medicare pay cuts to physicians for one year, a deal that is expected to cost more than $19 billion. A vote on the measure could happen as early as today.
Abbott Laboratories, B. Braun Medical and Boehringer Ingelheim Roxane have agreed to pay $421 million to settle False Claims Act allegations, the Justice Department announced Tuesday.
A study by the Lewin Group, conducted for the Pharmaceutical Care Management Association, indicates Medicaid could save $30 billion over 10 years in pharmacy expenses by transitioning away from its current predominant fee-for-service payment model.